Effects of diet-induced obesity in the development of lymphedema in the animal model: A literature review

Escobedo, 2017, The lymphatic vasculature: its role in adipose metabolism and obesity, Cell Metab, 26, 598, 10.1016/j.cmet.2017.07.020 Harvey, 2005, Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity, Nat Genet, 37, 1072, 10.1038/ng1642 Zampell, 2012, Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation, Plast Reconstr Surg, 129, 825, 10.1097/PRS.0b013e3182450b2d Savetsky, 2014, Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema, Am J Physiol Heart Circ Physiol, 307, H165, 10.1152/ajpheart.00244.2014 Weitman, 2013, Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes, PLoS One, 8, 10.1371/journal.pone.0070703 Blum, 2014, Chronic high-fat diet impairs collecting lymphatic vessel function in mice, PLoS One, 9, 10.1371/journal.pone.0094713 Garcia Nores, 2016, Obesity but not high-fat diet impairs lymphatic function, Int J Obes (Lond), 40, 1582, 10.1038/ijo.2016.96 Vuorio, 2014, Lymphatic vessel insufficiency in hypercholesterolemic mice alters lipoprotein levels and promotes atherogenesis, Arterioscler Thromb Vasc Biol, 34, 1162, 10.1161/ATVBAHA.114.302528 Park, 2016, Prevalence and epidemiological factors involved in cellulitis in korean patients with lymphedema, Ann Rehabil Med, 40, 326, 10.5535/arm.2016.40.2.326 Versini, 2014, Obesity in autoimmune diseases: not a passive bystander, Autoimmun Rev, 13, 981, 10.1016/j.autrev.2014.07.001 Schmitz, 2013, Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity, J Natl Cancer Inst, 105, 1344, 10.1093/jnci/djt223 Kim, 2014, Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer, J Immunol Res, 2014, 10.1155/2014/349546 Novosad, 2013, Role of obesity in asthma control, the obesity-asthma phenotype, J Allergy (Cairo), 2013 Murray, 2011, Protective and pathogenic functions of macrophage subsets, Nat Rev Immunol, 11, 723, 10.1038/nri3073 WHO. Global Health Observatory data repository World Health Organization2016 [Available from: http://apps.who.int/gho/data/view.main.REGION2480A?lang=en. Greene AK, Borud LJ, Slavin SA. Chapter 96 - Lymphedema. In: Weinzweig J, editor. Plastic Surgery Secrets Plus (Second Edition). Philadelphia: Mosby; 2010. p. 630–5. Hooijmans, 2014, SYRCLE’s risk of bias tool for animal studies, BMC Med Res Methodol, 14, 43, 10.1186/1471-2288-14-43 Gousopoulos, 2017, High-fat diet in the absence of obesity does not aggravate surgically induced lymphoedema in mice, Eur Surg Res, 58, 180, 10.1159/000461579 Torrisi, 2016, Inhibition of inflammation and inos improves lymphatic function in obesity, Sci Rep, 6, 19817, 10.1038/srep19817 Nitti, 2016, Obesity-induced lymphatic dysfunction is reversible with weight loss, J Physiol, 594, 7073, 10.1113/JP273061 Kim, 2008, Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice, Obes (Silver Spring), 16, 1261, 10.1038/oby.2008.55 Magnuson, 2017, Diet-induced obesity causes visceral, but not subcutaneous, lymph node hyperplasia via increases in specific immune cell populations, Cell Prolif, 50, 10.1111/cpr.12365 Magnuson, 2020, High-fat diet induced central adiposity (visceral fat) is associated with increased fibrosis and decreased immune cellularity of the mesenteric lymph node in mice, Eur J Nutr, 59, 1641, 10.1007/s00394-019-02019-z Solt, 2019, Obesity-induced immune dysfunction and immunosuppression: TEM observation of visceral and subcutaneous lymph node microarchitecture and immune cell interactions, Horm Mol Biol Clin Invest, 39 Hespe, 2016, Exercise training improves obesity-related lymphatic dysfunction, J Physiol, 594, 4267, 10.1113/JP271757 Savetsky, 2015, Lymphatic function regulates contact hypersensitivity dermatitis in obesity, J Invest Dermatol, 135, 2742, 10.1038/jid.2015.283 Lim, 2009, Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration, Am J Pathol, 175, 1328, 10.2353/ajpath.2009.080963 Greene, 2012, Lower-extremity lymphedema and elevated body-mass index, N Engl J Med, 366, 2136, 10.1056/NEJMc1201684 Arngrim, 2013, Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation?, Int J Obes, 37, 748, 10.1038/ijo.2012.98 Ribeiro Pereira, 2017, Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up, Breast (Edinb, Scotl), 36, 67, 10.1016/j.breast.2017.09.006 Tsai, 2018, Lymphedema following breast cancer: The importance of surgical methods and obesity, Front Women’s Health, 3, 10.15761/FWH.1000144 Geller, 2003, Factors associated with arm swelling after breast cancer surgery, J Women’S Health (2002), 12, 921, 10.1089/154099903770948159 Helyer, 2010, Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients, Breast J, 16, 48, 10.1111/j.1524-4741.2009.00855.x Clark, 2005, Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study, QJM: Mon J Assoc Physicians, 98, 343, 10.1093/qjmed/hci053 Dominick, 2013, Risk factors associated with breast cancer-related lymphedema in the WHEL Study, J Cancer Surviv: Res Pract, 7, 115, 10.1007/s11764-012-0251-9 DiSipio, 2013, Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis, Lancet Oncol, 14, 500, 10.1016/S1470-2045(13)70076-7 Ahmed, 2011, Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study, Breast Cancer Res Treat, 130, 981, 10.1007/s10549-011-1667-z Meric, 2002, Long-term complications associated with breast-conservation surgery and radiotherapy, Ann Surg Oncol, 9, 543, 10.1007/BF02573889 Kwan, 2011, Exercise in patients with lymphedema: a systematic review of the contemporary literature, J Cancer Surviv, 5, 320, 10.1007/s11764-011-0203-9 Shaw, 2007, A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema, Cancer, 110, 1868, 10.1002/cncr.22994 Saaristo, 2002, Insights into the molecular pathogenesis and targeted treatment of lymphedema, Ann N Y Acad Sci, 979, 94, 10.1111/j.1749-6632.2002.tb04871.x Fink, 2004, Serum level of VEGF-D in patients with primary lymphedema, Lymphology, 37, 185 Triana, 2017, Sirolimus in the treatment of vascular anomalies, Eur J Pedia Surg, 27, 86 Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema [Internet]. NIH. 2018 [cited December 6th]. Available from: https://clinicaltrials.gov/ct2/show/NCT03658967. Ahmadzadeh, 2020, Human adipose-derived stem cells support lymphangiogenesis in vitro by secretion of lymphangiogenic factors, Exp Cell Res, 388, 10.1016/j.yexcr.2020.111816 Hadrian, 2017, Animal models of secondary lymphedema: new approaches in the search for therapeutic options, Lymphat Res Biol, 15, 2, 10.1089/lrb.2016.0015 Weitman, 2013, Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes, PLoS ONE, 8, 10.1371/journal.pone.0070703